Table 3.
Quality of life measures showing Short Form-36 Physical Component scores by group at six and 12 months.
Group | SF-36 score | St Dev | SF improvement | P value |
---|---|---|---|---|
ACZ to open-label ACZ | 51.7 | 7.51 | ||
52.28 | 8.08 | 0.58 | 0.67 | |
PLB to open-label ACZ | 49.51 | 8.69 | ||
51.56 | 8.48 | 2.05 | 0.05 | |
ACZ tapered off ACZ | 52.38 | 5.76 | ||
53.51 | 8.60 | 1.13 | 0.53 | |
PLB to no ACZ | 55.26 | 4.66 | ||
57.11 | 3.71 | 1.85 | 0.26 |
ACZ = acetazolamide, PLB = placebo, SF = short form